BUZZ-Merck rises as drugmaker revamps human health business
Reuters
Yesterday
BUZZ-Merck rises as drugmaker revamps human health business
Updates
** Shares of drugmaker Merck MRK.N rise 1.5% to $124.10 premarket
** Co says it will split its human health operations into an Oncology unit and a Specialty, Pharma & Infectious Diseases unit to improve performance ahead of multiple product launches
** Co says Jannie Oosthuizen will lead oncology; Brian Foard joins from SanofiSASY.PAto head the second unit starting March 2
** Says restructuring supports its late‑stage pipeline, which includes about 80 late‑stage studies and more than 20 potential new products
** Co also names Chirfi Guindo as executive vice president for Strategic Access, Policy & Communication
** Merck shares rose ~6% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.